TITAN PHARMACEUTICAL INC
TTP
TTP was delisted on the 24th of December, 2008.
2 hedge funds and large institutions have $245K invested in TITAN PHARMACEUTICAL INC in 2015 Q3 according to their latest regulatory filings, with 0 funds opening new positions, increasing their positions, 1 reducing their positions, and 2 closing their positions.
13% less capital invested
Capital invested by funds: $282K → $245K (-$36.8K)
50% less funds holding
Funds holding: 4 → 2 (-2)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 2
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GS
Gagnon Securities
New York
|
-$1.09M |
| 2 |
VIA
Vantage Investment Advisors
State College,
Pennsylvania
|
-$10K |
| 3 |
ECM
Estabrook Capital Management
New York
|
-$800 |
TTP Hedge Fund Activity: Q3 2015 in Review
2 of the 3,582 institutional investors tracked by Wall St. Rank reported a position in TITAN PHARMACEUTICAL INC (TTP) for Q3 2015, worth a combined $245K — down 13% from $282K a quarter earlier.
Sellers outnumbered buyers: 2 funds closed out of TTP and 0 opened new positions — a net loss of 2 holders — while 1 trimmed existing stakes and 0 added.
The largest seller was Gagnon Securities, cutting an estimated $1.09M.
- 2 institutional investors held TITAN PHARMACEUTICAL INC (TTP) as of Q3 2015, down from 4 in Q2 2015.
- Funds reported $245K of TITAN PHARMACEUTICAL INC stock for Q3 2015, down 13% quarter-over-quarter.
- 0 funds opened new TITAN PHARMACEUTICAL INC positions in Q3 2015 and 2 closed out, a net change of -2 holders.
- The largest TITAN PHARMACEUTICAL INC seller in Q3 2015 was Gagnon Securities, an estimated $1.09M sold.
Based on aggregated 13F filings for Q3 2015.